• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯氮平单一疗法对精神分裂症患者肠道微生物群和代谢的影响。

Impact of clozapine monotherapy on gut microbiota and metabolism in people with schizophrenia.

作者信息

Yin Feiyan, Shi Zhidao, Ma Xiquan, Ding Kai, Zhang Yuan, Ma Sha

机构信息

Clinical Research Center for Mental Disorders, Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University, Shanghai, China.

Department of Developmental and Behavioral Pediatrics, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

出版信息

Front Microbiol. 2023 Sep 6;14:1253156. doi: 10.3389/fmicb.2023.1253156. eCollection 2023.

DOI:10.3389/fmicb.2023.1253156
PMID:37744899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10512059/
Abstract

BACKGROUND

Clozapine is considered one of the most effective antipsychotic drugs, but it is most likely to cause metabolic abnormalities. Researchers have studied the causes of metabolic abnormalities caused by clozapine from multiple perspectives, but the reasons remain unclear.

PURPOSE

Characterize the gut microbiota of people with schizophrenia taking clozapine, exploring the association between gut microbiota and glucose lipid metabolic markers in schizophrenia patients taking clozapine.

RESEARCH DESIGN

Sixty-one long-term inpatients with schizophrenia in clozapine monotherapy were selected as study subjects. We got four subgroups by sex and the presence of metabolic syndrome.

DATA ANALYSIS

16s analysis technology was applied at the genus level to determine the classification of gut microbiota. Then we compared the characteristics of gut microbiota and the association of gut microbiota with glucose lipid metabolic markers in each group.

FINDINGS

We found differences in the diversity of gut microbiota among groups. The association between gut microbiota and glucose lipid metabolic markers was complicated. Gender was an important differentiating factor. has a low abundance. However, it was the only genus associated with glycemic or lipids in each group. Among metabolic syndromes, was positively correlated with most lipids in females but negatively correlated in males, showing gender differences. In female non-metabolic syndromes, lost its probiotic character; instead, showing pathogenicity, which has strong positive correlations with fasting blood glucose and low-density lipoprotein but negative correlations with Apolipoprotein A1. Maybe schizophrenia, taking clozapine, and gender factors influenced the gut microbiota, which complicated our findings. The significance of the results remains to be determined by in-depth studies.

摘要

背景

氯氮平被认为是最有效的抗精神病药物之一,但它最有可能导致代谢异常。研究人员已从多个角度研究了氯氮平引起代谢异常的原因,但原因仍不清楚。

目的

对服用氯氮平的精神分裂症患者的肠道微生物群进行特征分析,探索服用氯氮平的精神分裂症患者肠道微生物群与糖脂代谢标志物之间的关联。

研究设计

选取61例长期接受氯氮平单药治疗的精神分裂症住院患者作为研究对象。根据性别和是否存在代谢综合征将其分为四个亚组。

数据分析

在属水平上应用16s分析技术来确定肠道微生物群的分类。然后我们比较了各组肠道微生物群的特征以及肠道微生物群与糖脂代谢标志物的关联。

研究结果

我们发现各组肠道微生物群的多样性存在差异。肠道微生物群与糖脂代谢标志物之间的关联很复杂。性别是一个重要的区分因素。[此处原文缺失具体菌属名称]丰度较低。然而,它是每组中唯一与血糖或血脂相关的菌属。在代谢综合征患者中,[此处原文缺失具体菌属名称]在女性中与大多数血脂呈正相关,而在男性中呈负相关,表现出性别差异。在女性非代谢综合征患者中,[此处原文缺失具体菌属名称]失去了益生菌特性;相反,表现出致病性,与空腹血糖和低密度脂蛋白呈强正相关,但与载脂蛋白A1呈负相关。也许精神分裂症、服用氯氮平和性别因素影响了肠道微生物群,这使得我们的研究结果变得复杂。结果的意义仍有待深入研究来确定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c870/10512059/80cd6eda5af9/fmicb-14-1253156-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c870/10512059/0afcf191d6d8/fmicb-14-1253156-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c870/10512059/04cd22e45f09/fmicb-14-1253156-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c870/10512059/e08a37f4530f/fmicb-14-1253156-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c870/10512059/80cd6eda5af9/fmicb-14-1253156-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c870/10512059/0afcf191d6d8/fmicb-14-1253156-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c870/10512059/04cd22e45f09/fmicb-14-1253156-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c870/10512059/e08a37f4530f/fmicb-14-1253156-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c870/10512059/80cd6eda5af9/fmicb-14-1253156-g004.jpg

相似文献

1
Impact of clozapine monotherapy on gut microbiota and metabolism in people with schizophrenia.氯氮平单一疗法对精神分裂症患者肠道微生物群和代谢的影响。
Front Microbiol. 2023 Sep 6;14:1253156. doi: 10.3389/fmicb.2023.1253156. eCollection 2023.
2
Investigation of the Gut Microbiome in Patients with Schizophrenia and Clozapine-Induced Weight Gain: Protocol and Clinical Characteristics of First Patient Cohorts.精神分裂症患者肠道微生物组与氯氮平诱导体重增加的研究:首个患者队列的方案和临床特征。
Neuropsychobiology. 2020;79(1):5-12. doi: 10.1159/000494696. Epub 2019 Mar 29.
3
Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.载脂蛋白C3、载脂蛋白A5和脂蛋白脂肪酶基因的等位基因变异以及第一代和第二代抗精神病药物对精神分裂症患者血脂的影响。
Pharmacogenomics J. 2008 Jun;8(3):228-36. doi: 10.1038/sj.tpj.6500474. Epub 2007 Aug 28.
4
Antipsychotic-induced gastrointestinal hypomotility and the alteration in gut microbiota in patients with schizophrenia.抗精神病药引起的胃肠道动力不足和精神分裂症患者肠道微生物群的改变。
Brain Behav Immun. 2022 Jan;99:119-129. doi: 10.1016/j.bbi.2021.09.014. Epub 2021 Sep 24.
5
Serum levels of AgRP protein in patients with schizophrenia on clozapine monotherapy.接受氯氮平单一疗法的精神分裂症患者的血清AgRP蛋白水平。
Metab Brain Dis. 2015 Apr;30(2):529-35. doi: 10.1007/s11011-014-9592-6. Epub 2014 Jul 19.
6
Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol.体重增加、代谢参数以及种族对随机接受双盲氯氮平、奥氮平或氟哌啶醇治疗的攻击性住院患者的影响。
Schizophr Res. 2009 May;110(1-3):95-102. doi: 10.1016/j.schres.2009.02.006. Epub 2009 Mar 9.
7
Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia.脂联素作为中国精神分裂症患者服用氯氮平后代谢综合征的潜在生物标志物。
J Clin Psychiatry. 2007 Dec;68(12):1834-9. doi: 10.4088/jcp.v68n1202.
8
Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.使用非典型抗精神病药物治疗的精神分裂症患者的葡萄糖代谢:频繁采样静脉葡萄糖耐量试验和最小模型分析
Arch Gen Psychiatry. 2005 Jan;62(1):19-28. doi: 10.1001/archpsyc.62.1.19.
9
High prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine.使用氯氮平或奥氮平治疗的超重或肥胖精神分裂症患者中,糖尿病前期和代谢异常的高患病率。
CNS Spectr. 2019 Aug;24(4):441-452. doi: 10.1017/S1092852918001311. Epub 2018 Dec 31.
10
Differences in gut microbiota and its metabolic function among different fasting plasma glucose groups in Mongolian population of China.中国蒙古族人群不同空腹血糖组间肠道微生物群及其代谢功能的差异。
BMC Microbiol. 2023 Apr 15;23(1):102. doi: 10.1186/s12866-023-02852-7.

引用本文的文献

1
Bibliometric Analysis of Antipsychotic-induced Metabolic Disorder from 2006 to 2021 Based on WoSCC Database.基于WoSCC数据库的2006年至2021年抗精神病药物所致代谢紊乱的文献计量分析
Curr Neuropharmacol. 2025;23(4):439-457. doi: 10.2174/1570159X23666241016090634.

本文引用的文献

1
The regulatory effects of second-generation antipsychotics on lipid metabolism: Potential mechanisms mediated by the gut microbiota and therapeutic implications.第二代抗精神病药物对脂质代谢的调节作用:肠道微生物群介导的潜在机制及治疗意义。
Front Pharmacol. 2023 Jan 25;14:1097284. doi: 10.3389/fphar.2023.1097284. eCollection 2023.
2
The antipsychotic drug olanzapine altered lipid metabolism in the common carp (Cyprinus carpio L.): Insight from the gut microbiota-SCFAs-liver axis.抗精神病药物奥氮平改变了鲤鱼(Cyprinus carpio L.)的脂质代谢:来自肠道微生物群-SCFA-肝脏轴的见解。
Sci Total Environ. 2023 Jan 15;856(Pt 1):159054. doi: 10.1016/j.scitotenv.2022.159054. Epub 2022 Sep 26.
3
Olanzapine-induced lipid disturbances: A potential mechanism through the gut microbiota-brain axis.
奥氮平引起的脂质紊乱:一种通过肠道微生物群-脑轴的潜在机制。
Front Pharmacol. 2022 Aug 5;13:897926. doi: 10.3389/fphar.2022.897926. eCollection 2022.
4
A Focused Review of the Metabolic Side-Effects of Clozapine.氯氮平的代谢副作用集中综述。
Front Endocrinol (Lausanne). 2021 Feb 25;12:609240. doi: 10.3389/fendo.2021.609240. eCollection 2021.
5
Taxonomic Composition and Diversity of the Gut Microbiota in Relation to Habitual Dietary Intake in Korean Adults.肠道微生物群与韩国成年人习惯性饮食摄入的关系的分类组成和多样性。
Nutrients. 2021 Jan 26;13(2):366. doi: 10.3390/nu13020366.
6
Gut microbiota: An intermediary between metabolic syndrome and cognitive deficits in schizophrenia.肠道微生物群:代谢综合征与精神分裂症认知缺陷之间的中介。
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110097. doi: 10.1016/j.pnpbp.2020.110097. Epub 2020 Sep 8.
7
Gut microbiota in human metabolic health and disease.人体肠道微生物群与代谢健康和疾病。
Nat Rev Microbiol. 2021 Jan;19(1):55-71. doi: 10.1038/s41579-020-0433-9. Epub 2020 Sep 4.
8
Altered gut microbiota associated with symptom severity in schizophrenia.精神分裂症中与症状严重程度相关的肠道微生物群改变。
PeerJ. 2020 Jul 29;8:e9574. doi: 10.7717/peerj.9574. eCollection 2020.
9
Gut Microbiota Associations with Metabolic Health and Obesity Status in Older Adults.老年人肠道微生物群与代谢健康和肥胖状况的关联。
Nutrients. 2020 Aug 7;12(8):2364. doi: 10.3390/nu12082364.
10
The Association of Gut Microbiota With Idiopathic Central Precocious Puberty in Girls.女童肠道微生物群与特发性中枢性性早熟的关联
Front Endocrinol (Lausanne). 2020 Jan 22;10:941. doi: 10.3389/fendo.2019.00941. eCollection 2019.